Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Knatterud

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Journal of the American College of Cardiology|November 25, 2000
Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial InvestigatorsM J Domanski, C B Borkowf, L Campeau, et al.
The American Journal of Cardiology|June 1, 1997
Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry)H V Anderson, R S Gibson, P H Stone, et al.
The American Journal of Cardiology|July 15, 1996
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)R C Becker, C P Cannon, E G Bovill, et al.
Journal of the American College of Cardiology|May 1, 1992
Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) studyN S Kleiman, M Terrin, H Mueller, et al.
Transactions of the American Clinical and Climatological Association|January 1, 1994
Asymptomatic cardiac ischemia pilot (ACIP)C R Conti, M G Bourassa, B R Chaitman, et al.
The American Journal of Cardiology|July 15, 1994
Comparison of patients with < 60% to > or = 60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. The TIMI InvestigatorsM J Schweiger, R P McMahon, M L Terrin, et al.
Investigative Ophthalmology & Visual Science|March 7, 1998
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18M D Davis, M R Fisher, R E Gangnon, et al.
Controlled Clinical Trials|September 19, 1998
Guidelines for quality assurance in multicenter trials: a position paperG L Knatterud, F W Rockhold, S L George, et al.
Journal of the American College of Cardiology|April 1, 1990
The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectivesD S Baim, E Braunwald, F Feit, et al.
Journal of the American College of Cardiology|December 1, 1993
Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trialM L Terrin, D O Williams, N S Kleiman, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Journal of the American College of Cardiology|November 25, 2000
Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial InvestigatorsM J Domanski, C B Borkowf, L Campeau, et al.
The American Journal of Cardiology|June 1, 1997
Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry)H V Anderson, R S Gibson, P H Stone, et al.
The American Journal of Cardiology|July 15, 1996
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)R C Becker, C P Cannon, E G Bovill, et al.
Journal of the American College of Cardiology|May 1, 1992
Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) studyN S Kleiman, M Terrin, H Mueller, et al.
Transactions of the American Clinical and Climatological Association|January 1, 1994
Asymptomatic cardiac ischemia pilot (ACIP)C R Conti, M G Bourassa, B R Chaitman, et al.
The American Journal of Cardiology|July 15, 1994
Comparison of patients with < 60% to > or = 60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. The TIMI InvestigatorsM J Schweiger, R P McMahon, M L Terrin, et al.
Investigative Ophthalmology & Visual Science|March 7, 1998
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18M D Davis, M R Fisher, R E Gangnon, et al.
Controlled Clinical Trials|September 19, 1998
Guidelines for quality assurance in multicenter trials: a position paperG L Knatterud, F W Rockhold, S L George, et al.
Journal of the American College of Cardiology|April 1, 1990
The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectivesD S Baim, E Braunwald, F Feit, et al.
Journal of the American College of Cardiology|December 1, 1993
Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trialM L Terrin, D O Williams, N S Kleiman, et al.
Pageof 8